ISFAHAN UNIVERSITY OF MEDICAL SCIENCES
๐ฎ๐ทIran
- Country
- ๐ฎ๐ทIran
- Ownership
- Private
- Established
- 1024-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.mui.ac.ir
The Effectiveness of Astaxanthin Supplementation on the Clinical Symptoms and Cardio-metabolic Profile in Women with Polycystic Ovary Syndrome
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 44
- Registration Number
- NCT06642363
- Locations
- ๐ฎ๐ท
Isfahan university of medical sciences, Isfahan, Iran, Islamic Republic of
Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2
Recruiting
- Conditions
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 52
- Registration Number
- NCT06595355
Mesenchymal Stem Cells Derived Exosomes in Osteoarthritis Patients
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT06466850
- Locations
- ๐ฎ๐ท
Leila Dehghani, Isfahan, Iran, Islamic Republic of
Effectiveness of Intrauterine Growth Hormone Administration as an add-on Therapy to Conventional Hormone Therapy Compared to Placebo in Patients With Thin Endometrium Undergoing Frozen Thawed Embryo Transfer
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-23
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 54
- Registration Number
- NCT06379659
- Locations
- ๐ฎ๐ท
Isfahan Shahid Beheshti hospital, Hazrat e Maryam Fertility Center, Isfahan, Iran, Islamic Republic of
Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2023-08-02
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 74
- Registration Number
- NCT05973253
- Locations
- ๐ฎ๐ท
Isfahan Eye Research Center, Isfahan, Iran, Islamic Republic of
๐ฎ๐ทIsfahan eyes research centre, Isfahan, Iran, Islamic Republic of
Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT05813379
- Locations
- ๐ฎ๐ท
Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of
Exosome Effect on Prevention of Hairloss
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 20
- Registration Number
- NCT05658094
- Locations
- ๐ฎ๐ท
Leila Dehghani, Isfahan, Iran, Islamic Republic of
Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-11-29
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 150
- Registration Number
- NCT05630222
- Locations
- ๐ฎ๐ท
Al-Zahra University Hospital, Isfahan, Iran, Islamic Republic of
Efficacy of Pilocarpine 1% in Presbyopia
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-13
- Last Posted Date
- 2022-10-13
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 25
- Registration Number
- NCT05578001
- Locations
- ๐ฎ๐ท
Isfahan Eye Research Center, Isfahan, Iran, Islamic Republic of
Intraorbital Dermoid/Epidermoid Cyst
Completed
- Conditions
- First Posted Date
- 2022-06-08
- Last Posted Date
- 2022-06-08
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 9
- Registration Number
- NCT05410431
ยฉ Copyright 2024. All Rights Reserved by MedPath